Summary: The Health Care sector faces uncertainty due to speculation about Robert F. Kennedy, Jr.
tumeyes/iStock via Getty Images A phase 3 trial of Johnson & Johnson’s (NYSE:JNJ) icotrokinra for
Solskin “We feel confident in being able to fund this as a fully cash deal,”
PeopleImages/iStock via Getty Images Medtech shouldn’t be greatly impacted if vaccine critic Robert F. Kennedy
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) has filed a lawsuit over a U.S.
Summary: In the second half of 2024, Johnson & Johnson made significant progress in developing
JHVEPhoto/iStock Editorial via Getty Images Johnson & Johnson filed suit against HHS on Tuesday in
Iryna Drozd Johnson & Johnson (NYSE:JNJ) has received FDA breakthrough therapy designation for its drug
Md Saiful Islam Khan/iStock via Getty Images Johnson & Johnson (NYSE:JNJ) has submitted applications to
designer491 The U.S. FDA has approved Johnson & Johnson MedTech’s (NYSE:JNJ) Varipulse, a device to